Edwards Lifesciences (EW) Free Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.09% |
| Dec 31, 2025 | 4.29% |
| Sep 30, 2025 | 35.55% |
| Jun 30, 2025 | 14.39% |
| Mar 31, 2025 | 12.43% |
| Dec 31, 2024 | -20.45% |
| Sep 30, 2024 | -3.65% |
| Jun 30, 2024 | 0.68% |
| Mar 31, 2024 | -23.89% |
| Dec 31, 2023 | -27.14% |
| Sep 30, 2023 | 6.73% |
| Jun 30, 2023 | -16.69% |
| Mar 31, 2023 | 18.50% |
| Dec 31, 2022 | -7.27% |
| Sep 30, 2022 | -1.42% |
| Jun 30, 2022 | 16.18% |
| Mar 31, 2022 | 13.82% |
| Dec 31, 2021 | 44.72% |
| Sep 30, 2021 | 13.42% |
| Jun 30, 2021 | 24.42% |
| Mar 31, 2021 | 19.62% |
| Dec 31, 2020 | 13.24% |
| Sep 30, 2020 | -5.04% |
| Jun 30, 2020 | -7.55% |
| Mar 31, 2020 | 18.93% |
| Dec 31, 2019 | 29.13% |
| Sep 30, 2019 | 59.40% |
| Jun 30, 2019 | -18.35% |
| Mar 31, 2019 | -18.40% |
| Dec 31, 2018 | 20.87% |
| Sep 30, 2018 | 40.97% |
| Jun 30, 2018 | -7.76% |
| Mar 31, 2018 | 2.53% |
| Dec 31, 2017 | 34.61% |
| Sep 30, 2017 | 20.52% |
| Jun 30, 2017 | 1.69% |
| Mar 31, 2017 | 34.32% |
| Dec 31, 2016 | -19.59% |
| Sep 30, 2016 | 21.22% |
| Jun 30, 2016 | 17.88% |
| Mar 31, 2016 | 139.86% |
| Dec 31, 2015 | 16.31% |
| Sep 30, 2015 | 12.80% |
| Jun 30, 2015 | 41.33% |
| Mar 31, 2015 | 60.04% |
| Dec 31, 2014 | 16.94% |
| Sep 30, 2014 | -9.99% |